Leap therapeutics reports third quarter 2023 financial results

Cambridge, mass. , nov. 13, 2023 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended september 30, 2023.

LPTX Ratings Summary

LPTX Quant Ranking